WAVE LIFE SCIENCES LTD. (F:1U5) — Market Cap & Net Worth
Market Cap & Net Worth: WAVE LIFE SCIENCES LTD. (1U5)
WAVE LIFE SCIENCES LTD. (F:1U5) has a market capitalization of $825.52 Million (€706.12 Million) as of September 20, 2026. Listed on the F stock exchange, this Germany-based company holds position #9850 globally and #1200 in its home market, demonstrating a -7.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WAVE LIFE SCIENCES LTD.'s stock price €3.67 by its total outstanding shares 192402202 (192.40 Million). Also see WAVE LIFE SCIENCES LTD. assets under control for a full breakdown of the balance sheet.
WAVE LIFE SCIENCES LTD. Market Cap History: 2018 to 2026
WAVE LIFE SCIENCES LTD.'s market capitalization history from 2018 to 2026. Data shows change from $7.84 Billion to $825.52 Million (-23.64% CAGR). Also see cash efficiency ratio of WAVE LIFE SCIENCES LTD. for how efficiently the company converts equity into cash flow.
WAVE LIFE SCIENCES LTD. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WAVE LIFE SCIENCES LTD.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for WAVE LIFE SCIENCES LTD. for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
77.92x
WAVE LIFE SCIENCES LTD.'s market cap is 77.92 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $601.04 Million | $40.96 Million | -$122.25 Million | 14.67x | N/A |
| 2022 | $1.43 Billion | $3.65 Million | -$161.82 Million | 390.82x | N/A |
| 2023 | $1.02 Billion | $113.31 Million | -$57.51 Million | 9.01x | N/A |
| 2024 | $2.74 Billion | $108.30 Million | -$97.01 Million | 25.34x | N/A |
| 2025 | $3.33 Billion | $42.73 Million | -$204.38 Million | 77.92x | N/A |
Competitor Companies of 1U5 by Market Capitalization
Companies near WAVE LIFE SCIENCES LTD. in the global market cap rankings as of September 20, 2026. Review 1U5 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to WAVE LIFE SCIENCES LTD. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $128.84 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #340 globally with a market cap of $79.38 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $60.28 Billion USD ( AU$85.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $128.84 Billion | $508.34 |
| #340 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.38 Billion | $784.85 |
| #459 | CSL Ltd | AU:CSL | $60.28 Billion | AU$175.59 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $154.04 |
WAVE LIFE SCIENCES LTD. Historical Marketcap From 2018 to 2026
Between 2018 and today, WAVE LIFE SCIENCES LTD.'s market cap moved from $7.84 Billion to $ 825.52 Million, with a yearly change of -23.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €825.52 Million | -75.20% |
| 2025 | €3.33 Billion | +21.31% |
| 2024 | €2.74 Billion | +168.72% |
| 2023 | €1.02 Billion | -28.39% |
| 2022 | €1.43 Billion | +137.28% |
| 2021 | €601.04 Million | -57.25% |
| 2020 | €1.41 Billion | -55.04% |
| 2019 | €3.13 Billion | -60.13% |
| 2018 | €7.84 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of WAVE LIFE SCIENCES LTD. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $825.52 Million USD |
| MoneyControl | $825.52 Million USD |
| MarketWatch | $825.52 Million USD |
| marketcap.company | $825.52 Million USD |
| Reuters | $825.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About WAVE LIFE SCIENCES LTD.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent diso… Read more